Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Posner

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2009
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neckL J Wirth, A M Allen, M R Posner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trialA D Colevas, P M Busse, C M Norris, et al.
Journal of Human Virology|July 5, 2001
Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade BW Xu, B A Smith-Franklin, P L Li, et al.
AIDS Research and Human Retroviruses|July 20, 1996
In vitro effects of anti-HIV immunotoxins directed against multiple epitopes on HIV type 1 envelope glycoprotein 160S H Pincus, K Wehrly, R Cole, et al.
Oral Oncology|July 27, 2019
Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients: The Quarterback trialK Misiukiewicz, V Gupta, B A Miles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term resultsJ R Clark, P M Busse, C M Norris, et al.
Journal of Medical Primatology|August 23, 2002
Postnatal pre- and postexposure passive immunization strategies: protection of neonatal macaques against oral simian-human immunodeficiency virus challengeR Hofmann-Lehmann, J Vlasak, R A Rasmussen, et al.
Nature Medicine|February 2, 2000
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infectionT W Baba, V Liska, R Hofmann-Lehmann, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 20, 2001
Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodiesR M Ruprecht, R Hofmann-Lehmann, B A Smith-Franklin, et al.
Journal of Medical Primatology|September 14, 2001
Passive immunization against oral AIDS virus transmission: an approach to prevent mother-to-infant HIV-1 transmission?R Hofmann-Lehmann, R A Rasmussen, J Vlasak, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2009
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neckL J Wirth, A M Allen, M R Posner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trialA D Colevas, P M Busse, C M Norris, et al.
Journal of Human Virology|July 5, 2001
Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade BW Xu, B A Smith-Franklin, P L Li, et al.
AIDS Research and Human Retroviruses|July 20, 1996
In vitro effects of anti-HIV immunotoxins directed against multiple epitopes on HIV type 1 envelope glycoprotein 160S H Pincus, K Wehrly, R Cole, et al.
Oral Oncology|July 27, 2019
Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients: The Quarterback trialK Misiukiewicz, V Gupta, B A Miles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term resultsJ R Clark, P M Busse, C M Norris, et al.
Journal of Medical Primatology|August 23, 2002
Postnatal pre- and postexposure passive immunization strategies: protection of neonatal macaques against oral simian-human immunodeficiency virus challengeR Hofmann-Lehmann, J Vlasak, R A Rasmussen, et al.
Nature Medicine|February 2, 2000
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infectionT W Baba, V Liska, R Hofmann-Lehmann, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 20, 2001
Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodiesR M Ruprecht, R Hofmann-Lehmann, B A Smith-Franklin, et al.
Journal of Medical Primatology|September 14, 2001
Passive immunization against oral AIDS virus transmission: an approach to prevent mother-to-infant HIV-1 transmission?R Hofmann-Lehmann, R A Rasmussen, J Vlasak, et al.
Pageof 11